Aspire Ventures Precision Medicine Fund
Aspire Universal and Penn Medicine Lancaster General Health (LG Health) have partnered to launch a unique $300 million impact fund to fast-track precision medicine technologies and practices that leverage AI and IoT to deliver affordable, individualized solutions at a massive scale. The unique fund aims to dramatically accelerate ventures by leveraging shared strategic resources, IP, and accelerator programs for R&D, clinical trials, insurance reimbursement, and health system adoption.
We are a multi-family office dedicated to building strategic partnerships and an ecosystem that reimagines healthcare delivery from end-to-end through technological innovation and precision medicine.